Literature DB >> 18417258

Delivery of vaccine peptides by rapid conjugation to baculovirus particles.

Sarah Wilson1, Margaret Baird, Vernon K Ward.   

Abstract

Baculoviruses deliver strong activation signals to dendritic cells and can promote potent immune responses. These properties can be harnessed to use baculovirus as an adjuvant and carrier particle for immunogenic peptides. In this study we use a chemical linker to couple peptides to the baculovirus Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV). Intranasal delivery of baculovirus coupled with immunogenic peptides to mice elicited antigen-specific IgG1 and IgG2a antibody. Furthermore, antigen-specific IgA was detected in the lung, and an IFN-gamma response was observed upon re-stimulation with antigen. We show that chemical coupling enables the rapid modification of AcMNPV, allowing multiple epitopes to be delivered simultaneously on a self-adjuvanting carrier particle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417258     DOI: 10.1016/j.vaccine.2008.03.027

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells.

Authors:  Chikako Ono; Akinori Ninomiya; Satomi Yamamoto; Takayuki Abe; Xiauyu Wen; Takasuke Fukuhara; Miwa Sasai; Masahiro Yamamoto; Tatsuya Saitoh; Takashi Satoh; Taro Kawai; Ken J Ishii; Shizuo Akira; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

2.  Baculovirus GP64-mediated entry into mammalian cells.

Authors:  Chikako Kataoka; Yuuki Kaname; Shuhei Taguwa; Takayuki Abe; Takasuke Fukuhara; Hideki Tani; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

3.  Bombyx mori nucleopolyhedrovirus displaying neospora caninum antigens as a vaccine candidate against N. caninum infection in mice.

Authors:  Tatsuya Kato; Takahiro Otsuki; Mai Yoshimoto; Kohei Itagaki; Tetsuya Kohsaka; Yumino Matsumoto; Kazunori Ike; Enoch Y Park
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

4.  Immunogenicity of a trivalent human papillomavirus L1 DNA-encapsidated, non-replicable baculovirus nanovaccine.

Authors:  Hansam Cho; Hee-Jung Lee; Yoon-Ki Heo; Yeondong Cho; Yong-Dae Gwon; Mi-Gyeong Kim; Ki Hoon Park; Yu-Kyoung Oh; Young Bong Kim
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

Review 5.  Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications.

Authors:  Chi-Yuan Chen; Chin-Yu Lin; Guan-Yu Chen; Yu-Chen Hu
Journal:  Biotechnol Adv       Date:  2011-04-28       Impact factor: 14.227

6.  Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2.

Authors:  Hansam Cho; Yuyeon Jang; Ki-Hoon Park; Hanul Choi; Aleksandra Nowakowska; Hee-Jung Lee; Minjee Kim; Min-Hee Kang; Jin-Hoi Kim; Ha Youn Shin; Yu-Kyoung Oh; Young Bong Kim
Journal:  NPJ Vaccines       Date:  2021-03-19       Impact factor: 7.344

Review 7.  Baculovirus-mediated gene delivery and RNAi applications.

Authors:  Kaisa-Emilia Makkonen; Kari Airenne; Seppo Ylä-Herttulala
Journal:  Viruses       Date:  2015-04-22       Impact factor: 5.048

8.  A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.

Authors:  Hyun-Jin Shin; Luis H Franco; Vidhya R Nair; Angela C Collins; Michael U Shiloh
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.